Drug Profile
Research programme: obesity/type 2 diabetes therapy - AdipoGenix
Alternative Names: AGX-0104; AGX-0119Latest Information Update: 13 Apr 2012
Price :
$50
*
At a glance
- Originator AdipoGenix
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Obesity; Type 2 diabetes mellitus
Most Recent Events
- 13 Apr 2012 Discontinued - Preclinical for Type-2 diabetes mellitus in USA (unspecified route)
- 07 Jun 2006 Preclinical trials in Obesity in USA (unspecified route)
- 07 Jun 2006 Preclinical trials in Type-2 diabetes mellitus in USA (unspecified route)